About
Liposphere is a biomedical start-up developing a platform of highly lubricous, water-based biocompatible nanomaterials for conditions in the human body where ultra-low friction is important. Liposphere's formulation can be used as a pure lubricant. It also has the potential to encapsulate active pharmaceutical ingredients in the future, for delivery of pharmaceuticals to targets that are currently difficult to reach. In addition, Liposphere's platform technology enables the coating of artificial medical surfaces such as contact lenses, catheters, and protheses, providing the potential for smooth movement in a wide range of biomedical devices. Liposphere's first orthopedic biolubricant product, AqueousJoint, will target osteoarthritis as an intra-articular injectable. Liposphere has also developed an ophthalmic formulation for the treatment of dry eye syndrome. The formulation aims to reduce discomfort and provide patient-friendly dosing schemes due its long-lasting effect as a boundary lubricant.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Liposphere founded and where is its headquarters located?
- Liposphere was founded in February 2019 and is headquartered in Ness Ziona, Israel.
- What is Liposphere's primary focus in biomedical development?
- Liposphere is developing a platform of highly lubricous, water-based biocompatible nanomaterials for conditions in the human body where ultra-low friction is important.
- What is Liposphere's first orthopedic product and its target condition?
- Liposphere's first orthopedic biolubricant product, AqueousJoint, is an intra-articular injectable targeting osteoarthritis.
- What ophthalmic formulation has Liposphere developed?
- Liposphere has developed an ophthalmic formulation for the treatment of dry eye syndrome, designed for long-lasting effect as a boundary lubricant.
- When did Liposphere receive its Seed funding round and who was an investor?
- Liposphere received its Seed funding round in November 2019, with Daniel Gamsu as an investor. For full financing history, please refer to startupim.
- When did Liposphere receive a grant and from which grantor?
- In June 2019, Liposphere received a grant from the IIA (Israel Innovation Authority).
- How many employees does Liposphere currently have?
- Liposphere currently has 32 employees, falling within the 11-50 employee bucket.
- What is the potential future application of Liposphere's formulation beyond pure lubrication?
- Liposphere's formulation has the potential to encapsulate active pharmaceutical ingredients for drug delivery to difficult-to-reach targets.
- What is another application of Liposphere's platform technology related to medical devices?
- Liposphere's platform technology enables the coating of artificial medical surfaces such as contact lenses, catheters, and prostheses, to provide smooth movement in biomedical devices.